| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the Joint Diseases Laboratory, Shriners Hospital for Children, and Departments of Surgery and Medicine,* McGill University, Montreal, Quebec; and The Ontario Cancer Institute,
University of Toronto, Toronto, Ontario, Canada
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is known to inhibit matrix metalloproteinases, aggrecanases, and tumor necrosis factor (TNF)-
-converting enzyme (TACE, ADAM17). These metalloproteases participate in different aspects of joint destruction in inflammatory arthritis. To determine the relative importance of this inhibitor in joint pathology, wild-type and Timp3/ mice were immunized with methylated bovine serum albumin followed by arthritis induction by intra-articular injection of the same antigen. Animals were monitored for up to 14 days after challenge, and joint tissues were analyzed by routine and Safranin O staining and for the presence of aggrecan neoepitopes produced by metalloprotease cleavage. Serum TNF-
was measured by immunoassay. Compared to wild-type animals, Timp3/ mice showed a dramatic increase in the initial inflammatory response to intra-articular antigen injection, and serum TNF-
levels were greatly elevated in the Timp3/ animals after immunization. However, these differences in clinical features disappeared by days 7 to 14. No difference in Safranin O staining or aggrecan cleavage site neoepitope abundance was seen. Thus, in inflammatory joint disease TIMP-3 likely dampens the inflammatory response of TNF-
by reducing ADAM17 activity.
This article has been cited by other articles:
![]() |
A. Janssen, J. Hoellenriegel, M. Fogarasi, H. Schrewe, M. Seeliger, E. Tamm, A. Ohlmann, C. A. May, B. H. F. Weber, and H. Stohr Abnormal Vessel Formation in the Choroid of Mice Lacking Tissue Inhibitor of Metalloprotease-3 Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2812 - 2822. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |